FIWBX
Price
$15.73
Change
-$0.01 (-0.06%)
Updated
Oct 17 closing price
Net Assets
3.15B
RLBEX
Price
$38.94
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.62B
Interact to see
Advertisement

FIWBX vs RLBEX

Header iconFIWBX vs RLBEX Comparison
Open Charts FIWBX vs RLBEXBanner chart's image
Fidelity Advisor Multi-Asset Income Z
Price$15.73
Change-$0.01 (-0.06%)
VolumeN/A
Net Assets3.15B
American Funds American Balanced R4
Price$38.94
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.62B
FIWBX vs RLBEX Comparison Chart in %
View a ticker or compare two or three
VS
FIWBX vs. RLBEX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIWBX is a Buy and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 266B vs. FIWBX (3.15B). FIWBX pays higher dividends than RLBEX: FIWBX (3.84) vs RLBEX (1.74). FIWBX was incepted earlier than RLBEX: FIWBX (7 years) vs RLBEX (23 years). FIWBX (0.74) is less costly to investors than RLBEX (0.59). FIWBX is a more actively managed with annual turnover of: 230.00 vs. RLBEX (44.00). FIWBX has a lower initial minimum investment than RLBEX: FIWBX (0) vs RLBEX (250). FIWBX annual gain was more profitable for investors over the last year : 14.03 vs. RLBEX (8.70). FIWBX return over 5 years is better than : 54.96 vs. RLBEX (42.04).
FIWBXRLBEXFIWBX / RLBEX
Total Expense Ratio0.740.59125%
Annual Report Gross Expense Ratio0.740.59125%
Fund Existence7 years23 years-
Gain YTD14.93314.631102%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.15B266B1%
Annual Yield % from dividends3.841.74221%
Returns for 1 year14.038.70161%
Returns for 3 years45.4150.5290%
Returns for 5 years54.9642.04131%
Returns for 10 yearsN/A77.69-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP15.380.38
+2.53%
Coeptis Therapeutics Holdings Inc
DHT12.110.23
+1.94%
DHT Holdings
PTLO5.900.02
+0.34%
Portillo's
ATMVU22.00N/A
N/A
AlphaVest Acquisition Corp
BBIO54.92-0.11
-0.20%
BridgeBio Pharma